Displaying One Session

Time
10:30 - 12:00

Welcome and introduction (ID 4875)

Defining unmet needs in advanced prostate cancer: The conundrum of the third line (ID 4876)

Available and emerging biomarker-driven targeted treatments in mCRPC (ID 4877)

Advances in imaging-based patient selection (ID 4878)

Live panel discussion: Managing the mCRPC patient in the new era of targeted treatment (ID 4879)

Live Q&A session (ID 4880)